News
European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk reported second-quarter sales up 18% on Wednesday, below initial analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback